A citation-based method for searching scientific literature

Ilana Cass, Rae Lynn Baldwin, Taz Varkey, Roxana Moslehi, Steven A Narod, Beth Y Karlan. Cancer 2003
Times Cited: 340



Andrew Tutt, Mark Robson, Judy E Garber, Susan M Domchek, M William Audeh, Jeffrey N Weitzel, Michael Friedlander, Banu Arun, Niklas Loman, Rita K Schmutzler, Andrew Wardley, Gillian Mitchell, Helena Earl, Mark Wickens, James Carmichael. Lancet 2010
Times Cited: 1241




List of shared articles



Times cited

The Potential Predictors in Chemotherapy Sensitivity.
Eun-Kyu Kim, Hee-Chul Shin. Adv Exp Med Biol 2021
0

Epithelial ovarian cancer risk: A review of the current genetic landscape.
Nicola Flaum, Emma J Crosbie, Richard J Edmondson, Miriam J Smith, Dafydd G Evans. Clin Genet 2020
10

Genomic insights in gynecologic cancer.
Erika Roddy, Jocelyn Chapman. Curr Probl Cancer 2017
5


Pharmacogenetic Predictors of Response.
Daniel L Hertz, James M Rae. Adv Exp Med Biol 2016
3

Synthetic lethality: the road to novel therapies for breast cancer.
Kiranjit K Dhillon, Ilirjana Bajrami, Toshiyasu Taniguchi, Christopher J Lord. Endocr Relat Cancer 2016
12

A comprehensive approach to the identification and management of the BRCA patient.
Christine Garcia, C Bethan Powell. Obstet Gynecol Surv 2015
3


The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
Dong Cho, Ho Park, See-Hyoung Park, Kyoung Kim, Myoung Chung, Woo Moon, Myoung Kang, Kyu Jang. J Ovarian Res 2015
14

The sooner the better: Genetic testing following ovarian cancer diagnosis.
E Fox, J McCuaig, R Demsky, C Shuman, D Chitayat, M Maganti, J Murphy, B Rosen, S Ferguson, S Randall Armel. Gynecol Oncol 2015
19


The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.
Arindam Paul, Soumen Paul. Front Biosci (Landmark Ed) 2014
69